REMYA UTHUP: Open Payments
NPI 1609476761 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$628 in 21 payments from 16 companies in 2025. Trend: 2023 $158 · 2024 $466 · 2025 $628
Food & beverage: $628
| Company | Payments | Amount |
|---|---|---|
| UROGEN PHARMA, INC. | 1 | $128 |
| BLUEWIND MEDICAL | 2 | $72 |
| Teleflex LLC | 2 | $64 |
| Verity Pharmaceuticals Inc. | 2 | $47 |
| Janssen Biotech, Inc. | 2 | $46 |
| PFIZER INC. | 2 | $36 |
| Boston Scientific Corporation | 1 | $32 |
| Daiichi Sankyo Inc. | 1 | $29 |
| Blue Earth Diagnostics | 1 | $27 |
| Procept Biorobotics Corporation | 1 | $25 |
Products named: JELMYTO, REVI, DEKNATEL, Tlando, XTANDI, AdVance XP, CARVYKTI, Enhertu.
Industry payments across FL — which companies pay providers there.
